Antibiotic Stewardship
Study suggests delivering high concentrations of antibiotics into the implantation site is feasible for infections in implanted CV electronic devices
13 Jan, 2023 | 13:26h | UTCRegional Antibiotic Delivery for Implanted Cardiovascular Electronic Device Infections – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries:
Direct Delivery of Antibiotics to CV Device Pocket Infections Appears Promising – TCTMD
Cohort Study | Antibiotic exposure linked to increased risk of inflammatory bowel disease
13 Jan, 2023 | 13:25h | UTCNews Release: Frequent use of antibiotics may heighten inflammatory bowel disease risk in over 40s – BMJ Newsroom
Commentaries:
Antibiotics may increase risk of inflammatory bowel disease, study finds – CIDRAP
Antibiotic Exposure Positively Linked to IBD Development – HealthDay
Commentary on Twitter
#GUTPressRelease on the paper by @AdamFayeMD, @KristineAllin, @manasiagrawalmd, @PREDICTIBD et al
"Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study" viahttps://t.co/zc9bG3CpSm#GUTInTheNews pic.twitter.com/xra8wfEgnr
— Gut Journal (@Gut_BMJ) January 9, 2023
RCT | Second-line levofloxacin-based quadruple therapy vs. bismuth-based quadruple therapy for Helicobacter pylori eradication
12 Jan, 2023 | 13:06h | UTCSecond-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary on Twitter
New research – Liou et al – Second-line levofloxacin-based quadruple therapy vs bismuth-based quadruple therapy for H pylori eradication and long-term changes to the gut #microbiota and antibiotic resistome: an RCThttps://t.co/Aipu3TRyFr#Hpylori #microbiome #AMR @emadelomar pic.twitter.com/aeFMAI3FCj
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) December 20, 2022
SR | Interventions for the eradication of methicillin‐resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
12 Jan, 2023 | 13:04h | UTC
Review | Early diagnosis and prevention of infections in cirrhosis
12 Jan, 2023 | 12:47h | UTCEarly Diagnosis and Prevention of Infections in Cirrhosis – Seminars in Liver Disease
RCT | Efficacy and safety of azithromycin vs. placebo to treat lower respiratory tract infections associated with low procalcitonin.
16 Dec, 2022 | 13:30h | UTCEfficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial – The Lancet Infectious Diseases (link to abstract – $ for full-text)
Commentary on Twitter
New research: Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trialhttps://t.co/EZW7YdxPPU pic.twitter.com/4zlsVN5NtT
— The Lancet Infectious Diseases (@TheLancetInfDis) December 14, 2022
SR | Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
14 Dec, 2022 | 14:51h | UTCTreatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins – Cochrane Library
Prevention of device-related infections in patients with cancer: Current practice and future horizons.
13 Dec, 2022 | 14:30h | UTC
WHO Report signals increasing resistance to antibiotics in bacterial infections in humans.
12 Dec, 2022 | 12:52h | UTCCommentary: WHO report shows rising antibiotic resistance, need for better data – CIDRAP
Commentary on Twitter (thread – click for more)
New WHO report on #AntimicrobialResistance reveals very high levels of resistance in common bacteria frequently causing bloodstream infections in hospitals.
Infection prevention & control is critical to stop the spread and save lives.
More: https://t.co/8dGqw5KgZT pic.twitter.com/XGC2I7KbwB
— World Health Organization (WHO) (@WHO) December 9, 2022
Approach to fever in patients with neutropenia: a review of diagnosis and management.
8 Dec, 2022 | 12:44h | UTCRelated:
Podcast | Procalcitonin revisited.
7 Dec, 2022 | 14:17h | UTCAnnals On Call – Procalcitonin Revisited – Annals of Internal Medicine
RCT | Efficacy of postoperative oral cephalexin and metronidazole on SSI in obese women undergoing cesarean section.
7 Dec, 2022 | 14:13h | UTC
Redefining Staphylococcus aureus bacteremia: a structured approach guiding diagnostic and therapeutic management.
5 Dec, 2022 | 00:20h | UTC
Commentary on Twitter
https://twitter.com/ABsteward/status/1594800589464293376
Under a Creative Commons Attribution (CC BY 4.0) license
Perspective | Push to use antibiotics to prevent sexually transmitted infections raises concerns.
2 Dec, 2022 | 14:27h | UTCPush to use antibiotics to prevent sexually transmitted infections raises concerns – Nature
German guideline on diverticular disease/diverticulitis.
30 Nov, 2022 | 13:41h | UTCEditorial: New German guidelines for the management of diverticulitis – UEG Journal
Related:
Systematic Review: Antibiotics for uncomplicated diverticulitis.
Efficacy and Safety of Non-Antibiotic Outpatient Treatment in Mild Acute Diverticulitis (DINAMO-study): A Multicentre, Randomised, Open-Label, Non-Inferiority Trial – Annals of Surgery (link to abstract – $ for full-text)
Elective surgical management of diverticulitis – Current Problems in Surgery
Management of Colonic Diverticulitis – Agency for Healthcare Research and Quality
Liposomal amphotericin B — Past, present and future.
29 Nov, 2022 | 14:03h | UTCLiposomal amphotericin B—the past – Journal of Antimicrobial Chemotherapy
Liposomal amphotericin B—the present – Journal of Antimicrobial Chemotherapy
Liposomal amphotericin B—the future – Journal of Antimicrobial Chemotherapy
RCT | Rezafungin vs. caspofungin for treatment of candidaemia and invasive candidiasis.
29 Nov, 2022 | 13:54h | UTCRezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial – The Lancet (link to abstract – $ for full-text)
Review | Infectious complications of abortion.
29 Nov, 2022 | 13:56h | UTCInfectious Complications of Abortion – Open Forum Infectious Diseases
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
27 Nov, 2022 | 22:30h | UTCCommentary: Report highlights the deadly impact of bacterial infections – CIDRAP
Commentary on Twitter (thread – click for more)
1 in 8 deaths are due to the deadliest bacterial pathogens in the world, making them the second-leading cause of death behind ischemic heart disease @TheLancethttps://t.co/PEPYvxRcqV pic.twitter.com/S6odJodsVj
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) November 21, 2022
RCT | Rectal culture-based vs. empirical antibiotic prophylaxis to prevent infections in men undergoing transrectal prostate biopsy.
27 Nov, 2022 | 22:28h | UTCRectal culture-based versus empirical antibiotic prophylaxis to prevent infectious complications in men undergoing transrectal prostate biopsy: a randomized, non-blinded multicenter trial – Clinical Infectious Diseases (link to abstract – $ for full-text)
Commentary on Twitter
RCT of rectal culture-based vs. empiric antibiotic prophylaxis to prevent infectious complications after transrectal prostate biopsy.
Potentially practice-changing study. Thoughts, @AshleyGWinter? @sigal_md Others? https://t.co/rJQusECapO @CIDJournal pic.twitter.com/94tBa2i1eN
— Paul Sax (@PaulSaxMD) November 24, 2022
RCT | Treatment of early Lyme Disease with doxycycline for 7 days is noninferior to treatment for 14 days.
23 Nov, 2022 | 14:06h | UTCTreatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial – The Lancet Infectious Diseases (link to abstract – $ for full-text)
Commentary: Shorter Duration of Antibiotics Noninferior for Lyme Disease – JAMA (free for a limited period)
Commentary on Twitter
New research: Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trialhttps://t.co/8lktc4gxzG pic.twitter.com/mP2e0Kn7C5
— The Lancet Infectious Diseases (@TheLancetInfDis) October 7, 2022
Epidemiology of ICU-onset bloodstream infection: prevalence, pathogens, and risk factors among 150,948 ICU patients.
21 Nov, 2022 | 14:14h | UTC
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.
18 Nov, 2022 | 13:23h | UTC
M-A | Efficacy and safety of treatments for different stages of syphilis.
18 Nov, 2022 | 13:20h | UTC
M-A | A short course of antibiotics is noninferior to long-course therapy in children with nonsevere pneumonia.
16 Nov, 2022 | 13:43h | UTCShort-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis – JAMA Pediatrics (free for a limited period)
Commentary: Review: Shorter antibiotic course sufficient for kids with pneumonia – CIDRAP
Related:
ACP Guidance: Appropriate Use of Short-Course Antibiotics in Common Infections
RCT: 7 days of antibiotic therapy as good as 14 days for afebrile men with urinary tract infection.
Meta-Analysis: Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia


